Tuesday, 21 March 2017

Two Cheers for Biogen's Court Victory

Biogen avoids a hit to best selling drug but growth issues persist.

from WSJ.com: Markets http://ift.tt/2mppURJ
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)